Page 21 - 83_02
P. 21
Sepsis biomarkers: A review 29. Clyne B, Olshaker JS. The C-reactive protein. J.
Emerg. Med. 1999; 17:1019–25.
Angus DC, et al. Sepsis, severe sepsis, and septic
shock: A review of the literature. African J. Emerg. 30. GP C. Procalcitonin and C-reactive protein during
Med. 2015; 5:127–35. systemic inflammatory response syndrome, sepsis and
organ dysfunction. Crit Care Med. 2004;8(4):234–42.
15. Marshall JC, Vincent JL, Fink MP, Cook DJ,
Rubenfeld G, Foster D, et al. Measures, markers, and 31. Rey Galán C. Biomarcadores de infección bacteriana
mediators: toward a staging system for clinical sepsis. grave: ¿ayudan en la práctica clínica? An Pediatría.
A report of the Fifth Toronto Sepsis Roundtable, 2016; 84: 247–8.
Toronto, Ontario, Canada, October 25-26, 2000. Crit.
Care Med. 2003; 31:1560–7. 32. Salinas La Casta M, López Garrigós M, Uris Selles J,
Leiva Salinas C. Variabilidad en la oferta y en la
16. Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. solicitud de determinaciones de laboratorio en
Crit Care. 2010;14(1):2-18. pacientes de servicios de urgencias hospitalarios.
Emergencias Rev. Soc. Española Med. Urgencias y
17. Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Emergencias. 2014; 26: 450-8.
Biomed. Res. Int. 2014;2014:e547818 6páginas.
33. Assicot M, Gendrel D, Carsin H, Raymond J,
18. Abbas N, Bednar I, Mix E, Marie S, Paterson D, Guilbaud J, Bohuon C. High serum procalcitonin
Ljungberg A, et al. Up-regulation of the inflammatory concentrations in patients with sepsis and infection.
cytokines IFN-gamma and IL-12 and down-regulation Lancet. 1993: 341: 515–8.
of IL-4 in cerebral cortex regions of APP(SWE)
transgenic mice. J Neuroimmunol. 2002; 126:50–7. 34. Domínguez-Comesaña E, López-Gómez V, Estevez-
Fernández SM, Mariño Padín E, Ballinas-Miranda J,
19. Jamilloux Y, Bourdonnay E, Gerfaud-Valentin M, Py Carrera-Dacosta E, et al. Procalcitonin and C-reactive
BF, Lefeuvre L, Barba T, et al. Interleukin-1, protein as early indicators of postoperative intra-
inflammasome and autoinflammatory diseases. Rev. abdominal infection after surgery for gastrointestinal
Med. Interne. 2016; 16:30472-6 cancer. Cirugía española. 2014;92(4):240–6.
20. Guzmán B, Correa D, Caballase E, Calderón C. 35. Meisner, M, Tschaikowsky, K, Schmidt J et al.
Citocinas y otras moléculas involucradas en sepsis y Procalcitonin (PCT)—Indications for a new diagnostic
en pacientes con sepsis y complicaciones de parameter of severe bacterial infection and sepsis in
neutropenia. Alergia, Asma r Inmunología transplantation, immunosuppression and cardiac assist
Pediátricas.2004; 13(1):15-23. devices. Cardiovasc. Eng. 1996;1:67.
21. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert 36. Brunkhorst FM, Forycki ZF, Beier W et al.
A, Franchimont P, et al. Sepsis and serum cytokine Procalcitonin immunoreactivity in severe human
concentrations. Crit. Care Med. 1997; 25:405–12. shock. Int Care Med. 1995;21(Suppl 1):12.
22. Rintala E, Pulkki K, Mertsola J, Nevalainen T, 37. Hedlund J, Hansson LO. Procalcitonin and C-reactive
Nikoskelainen J. Endotoxin, interleukin-6 and protein levels in community-acquired pneumonia:
phospholipase-A2 as markers of sepsis in patients Correlation with etiology and prognosis. Infection.
with hematological malignancies. Scand. J. Infect. 2000;28(2):68–73.
Dis. 1995; 27: 39–43.
38. Ma J, Wang S, Chen D, Duan J, Li C, Li G. The
23. Barriere SL, Lowry SF. An overview of mortality risk prognostic value of serum procalcitonin on severity of
prediction in sepsis. Crit. Care Med. 1995; 23:376– illness in non-sepsis critically ill patients. 2016:
93. 28:688–93.
24. Cernada M, Roqués V, Vento M. Interleuquina-6 y 39. Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter
diagnóstico de sepsis neonatal: algunas matizaciones. M, Becker KL, et al. In vitro and in vivo calcitonin I
Anales de Pediatría. 2010;73(2):104-105. gene expression in parenchymal cells: a novel product
of human adipose tissue. Endocrinology. 2003; 144:
25. Khialani AD, Espinosa MR. Proteína C reactiva y 5578–84.
enfermedad cardiovascular. Ed Cont Lab Clín. 13:59–
75. 40. Prat Aymerich C, Domínguez Benitez J.
Procalcitonina y marcadores de infección. Ed. Cont.
26. Thompson D, Pepys MB, Wood SP. The Lab. Clín. 2004;7:38–43.
physiological structure of human C-reactive protein
and its complex with phosphocholine. Structure. 41. Christ-Crain M, Müller B. Procalcitonin in bacterial
1999;7(2):169–77. infections--hype, hope, more or less? Swiss Med.
Wkly. 2005: 135: 451–60.
27. Colmenero AM, Pablo LR De, Nieto P, Martín S,
Sierra D, Mateos LS, et al. Apuntes de Ciencia 42. Masahira K, Gaku T, Naoya M, Tomohiro K. Serum
MARCADORES DE SEPSIS?: SITUACIÓN levels of soluble CD14 subtype reflect the APACHE
ACTUAL. 2014;1–13. II and SOFA Scores. Med Postgraduates.
2010;48(1):46–50.
28. Julián-Jiménez A, Candel-González FJ, González Del
Castillo J. Utilidad de los biomarcadores de 43. Liu B, Chen Y-X, Yin Q, Zhao Y-Z, Li C-S.
inflamación e infección en los servicios de urgencias.
Enferm Infecc Microbiol Clin. 2014;32:(3) 177–90. 185
@Real Academia Nacional de Farmacia. Spain
